IMMPNasdaq

Immutep Limited

Healthcare·Oncology·Phase 3·Sydney, NSW, Australia
Oncology

Immutep Limited (IMMP): 8 pipeline candidates. Updated within the last hour.

9.5/10

BioSniper Score

3-factor signal · derived from public data

Cash RunwayN/A

N/A

Financial Health9.9

D/E 0.09 · 0% dilution

Pipeline Maturity8.5

Lead: Phase 3

Pipeline Breadth10.0

8 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for Immutep Limitedacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$54.5M

Cash

$67.4M

Quarterly Burn

Runway

Revenue

Pipeline (8 candidates)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

24

Total value held

$483K

HolderSharesValue
blackrock, inc.810,926$285K
two sigma investments, lp124,760$44K
citadel advisors llc94,174$33K
xtx topco ltd73,837$26K
two sigma securities, llc53,590$19K
dimensional fund advisors lp30,409$11K
quadrature capital ltd26,910$9K
rhumbline advisers22,053$8K
jane street group, llc21,212$7K
millennium management llc20,802$7K

Showing top 10 of 24 institutional holders of Immutep Limited. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

·CEO: Mr. Marc Voigt

Frequently asked questions

How many drug candidates are in Immutep Limited's pipeline?

Immutep Limited (IMMP) has 8 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Immutep Limited's lead drug candidate?

Immutep Limited's most advanced tracked candidate is Avelumab (Phase 1) for Solid Tumors.

What is Immutep Limited's market capitalization?

Immutep Limited's market capitalization is approximately $54.5M.

Who is the CEO of Immutep Limited?

Mr. Marc Voigt is the chief executive officer of Immutep Limited (IMMP).

Get the full picture on Immutep Limited

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.